Exparel 1.3% 20ML 10S
Ended Awarded
- Contract number
- SPE2DX25FKVUZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $5,021
Award facts
- Contract value 100% obligated
- $5,021.26 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain. The contract was awarded on July 31, 2025, with an ultimate completion date of the same day, and carries no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management, representing a specialized pharmaceutical product for military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and effective through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products including prescription medications, biologics, and medical consumables.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement. The company maintains a robust portfolio of federal contract awards covering an extensive array of medications and medical products—from oncology treatments to vaccines and contraceptive devices—distributed directly to Department of Defense healthcare sites nationwide. The firm's consistent success in securing delivery orders without set-aside restrictions underscores its competitive positioning and capacity to fulfill the medical supply needs of military health facilities globally under the SPE2DB program framework.
Quick answers
Who was awarded contract SPE2DX25FKVUZ?
SPE2DX25FKVUZ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 31, 2025.
How much is contract SPE2DX25FKVUZ worth?
The government has obligated $5,021 on SPE2DX25FKVUZ.
Is contract SPE2DX25FKVUZ an order under another contract?
Yes. SPE2DX25FKVUZ is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVUZ competed?
The extent of competition for SPE2DX25FKVUZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award